MZKHT0411s Health technology assesment - p

Faculty of Medicine
spring 2024
Extent and Intensity
0/2/0. 4 credit(s). Type of Completion: zk (examination).
Teacher(s)
doc. MUDr. Regina Demlová, Ph.D. (lecturer)
PharmDr. Lenka Součková, Ph.D. (lecturer)
Mgr. Tereza Friessová (assistant)
Mgr. Bc. Alena Langaufová, Ph.D. (assistant)
Guaranteed by
doc. MUDr. Regina Demlová, Ph.D.
Department of Pharmacology – Theoretical Departments – Faculty of Medicine
Supplier department: Department of Pharmacology – Theoretical Departments – Faculty of Medicine
Timetable
Fri 1. 3. 14:30–18:40 F01B1/519, Fri 15. 3. 14:30–18:40 F01B1/519
Prerequisites (in Czech)
Ekonomika zdravotnictví a poskytovatelů zdravotních služeb II
Course Enrolment Limitations
The course is only offered to the students of the study fields the course is directly associated with.
fields of study / plans the course is directly associated with
Course objectives
In line with the introduction of new expensive medical technologies (innovative medicinal products and medical devices, imaging methods, screening programs, genetic testing, etc.) and specific need to enhance the efficiency of health spending costs there is the increasing pressure to evaluate these emerging healthcare technologies in clinical practice.
The main objectives of this seminars is to teach basic concepts and methods in HTA and to improve the capability to recognize, understand, and discuss theoretical frameworks in which specific concepts and methods are embedded.
Students will acquire knowledge about the historical background of evaluation in medicine in general and teach the basic concepts and methods of such evaluation in particular. Next, they will be introduced into the field of Health Technology Assessment (HTA), learn different approaches to HTA, and become familiar with the major subjects and developments in the field. Importantly, students will learn to identify the main problem that an intervention addresses, to measure this, to formulate hypothesis for HTA evaluation studies, and to assess the usefulness and relevance of this studies.
Learning outcomes
The student knows about the historical background of evaluation in general and health care evaluation in particular.
The student is introduced in the field of HTA and has learnt the various approaches to HTA.
The student is familiar with the major subjects and developments in the field of HTA.
The student has learnt to identify the main problem addressed by an intervention and how to measure its effect.
The student is able to formulate hypotheses for HTA studies and to assess their relevance.
The student is able to identify potential stakeholders in HTA evaluation studies
Syllabus
  • • HTA key principles and practice
  • • Data Sources for Health Technology Assessment
  • • HTA from different perspectives (agency, industry, decision-maker etc.)
  • • Economic evaluation and pricing, Costs and efficiency
  • • Patient-relevant outcome measures
  • • Calculating outcomes (QALYs, DALYs)
  • • Cost effectiveness analysis, budget impact
  • • Decision-analytic modeling for pharmacoeconomics
  • • Decision trees, state-transition and Markov models
  • • Handling uncertainty and variability
  • • EuNetHTA methodology
Literature
    required literature
  • • Berger ML, Bingefors K, Hedblom EC, Pashos CL, et al., editors. Health care cost, quality, and outcomes. Lawrenceville: ISPOR; 2003. 264 s. ISBN 0-9743289-0-1
    recommended literature
  • • Levin HM, McEwan PJ. Cost-effectiveness analysis: methods and applications. Second Edition ; SAGE;2001; str. 308. ISBN 0761919341
  • • Glick HA, Doshi JA, Sonnad SS, Polsky D. Economic evaluation in clinical trials. New York: Oxford University Press; 2007. 244 s. ISBN 978-0-19-852997-2
  • • Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, et al. Methods for the economic evaluation of health care programmes. third ed. New York: Oxford University Press; 2005. 379 s. ISBN 987-019-852945-3
  • • Walley T., Haycox A., Boland A. Pharmacoeconomics. ISBN-10: 0-443-07240-X. Imprint: CHURCHILL LIVINGSTONE 2003
  • • Rscati KL. Essentials of pharmacoeconomics. Baltimore: Lippincott Williams Wilkins; 2009. 250 s. ISBN 978-0-7817-6544-2
  • • Drummond M, McGuire A, editors. Economic evaluation in health care: merging theory with practice. New York: Oxford University Press; 2001. 286 s. ISBN 978-0-192-6317-63
  • • Gold MR, Siegel JE, Russell LB, Weinstein MC, editors. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996. 456 s. ISBN 978-0-19-510824-8
Teaching methods
lectures, group projects and discussions. Studying ALL MANDATORY LITERATURES
Assessment methods
REQUIREMENTS:

1. 100% attendance at seminars during the semester.
2. Absence will be excused only for serious medical reasons. Students must be aware that even in the case of excused absences (medical reasons) at least 80% attendance is required to obtain credit. In case the student has more than 20% excused or unexcused absence, he/she will have to repeat the course in the following semester.
3. Completion of assigned tasks. In case of unexcused absence, the student will be required to write a seminar paper for each absence. If the seminar paper is rejected due to deficiencies and is not corrected and re-submitted by the student for review, the student will not meet the requirements of the subject and will not get credit (see Policy of Absence and Late Arrivals, Academic Offenses, Plagiarism, and Unethical Behavior).
4. Active participation at seminars
Language of instruction
Czech
Further comments (probably available only in Czech)
Study Materials
Information on the extent and intensity of the course: 10.
The course is also listed under the following terms spring 2025.
  • Enrolment Statistics (recent)
  • Permalink: https://is.muni.cz/course/med/spring2024/MZKHT0411s